Emergent BioSolutions (EBS) Goodwill & Intangibles (2010 - 2026)
Emergent BioSolutions (EBS) posted quarterly Goodwill & Intangibles of $470.4 million for Q1 2026, down 3.05% year-over-year from $485.2 million in Q1 2025, and up 7.77% quarter-over-quarter from $436.5 million in Q4 2025.
Emergent BioSolutions (EBS) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
Emergent BioSolutions' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $470.4 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 3.05% year-over-year to $470.4 million; the TTM figure through Mar 2026 stood at $470.4 million (down 3.05% YoY), while the FY2025 annual figure was $436.5 million, down 12.96% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $470.4 million, up from $436.5 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $949.8 million in Q3 2022, with the low at $436.5 million in Q4 2025.
- The 5-year median for Goodwill & Intangibles is $550.4 million (2024), against an average of $630.5 million.
- The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles gained 14.17% in 2022, then tumbled 40.17% in 2023.
- Emergent BioSolutions' Goodwill & Intangibles stood at $947.0 million in 2022, then sank by 40.17% to $566.6 million in 2023, then dropped by 11.49% to $501.5 million in 2024, then declined by 12.96% to $436.5 million in 2025, then grew by 7.77% to $470.4 million in 2026.
- Business Quant data shows EBS's Goodwill & Intangibles at $470.4 million in Q1 2026, $436.5 million in Q4 2025, and $452.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Emergent BioSolutions | 251.81 Mn | 110.91 Mn | 137.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 261.80 Mn |
| Mar 31, 2026 | 470.40 Mn |
| Dec 31, 2025 | 436.50 Mn |
| Sep 30, 2025 | 452.70 Mn |
| Jun 30, 2025 | 469.00 Mn |
| Mar 31, 2025 | 485.20 Mn |
| Dec 31, 2024 | 501.50 Mn |
| Sep 30, 2024 | 517.80 Mn |
| Jun 30, 2024 | 534.10 Mn |
| Mar 31, 2024 | 550.40 Mn |
| Dec 31, 2023 | 566.60 Mn |
| Sep 30, 2023 | 582.80 Mn |
| Jun 30, 2023 | 811.00 Mn |
| Mar 31, 2023 | 827.10 Mn |
| Dec 31, 2022 | 947.00 Mn |
| Sep 30, 2022 | 949.80 Mn |
| Jun 30, 2022 | 801.50 Mn |
| Mar 31, 2022 | 815.50 Mn |
| Dec 31, 2021 | 829.50 Mn |
| Sep 30, 2021 | 885.10 Mn |